Menu

Diabetes Is Five Diseases, Not Two

The new classification system could help improve personalized medicine approaches to the disease.

Mar 5, 2018
Jim Daley

ISTOCK, ANDREY POPOV

Diabetes is a group of five diseases with distinct genetic and physiological profiles, according to a study published in The Lancet Diabetes & Endocrinology last week (March 1).

Traditionally, diabetes—a condition that affects more than 100 million Americans—has had just two classifications. However, clinicians were aware that type 1 and type 2 was “not a terribly accurate classification system” for the disease, Victoria Salem, a clinical scientist at Imperial College London who was not involved in the study, tells the BBC.

To identify more refined categories, researchers at the Lund University Diabetes Centre in Sweden and the Institute for Molecular Medicine in Finland analyzed the medical records and blood of 14,775 patients. They examined various diabetes-related measurements, such as long-term glycemic control, insulin resistance, and glycated hemoglobin, as well as genetic associations with the disease. Their investigation revealed five clusters of diabetic patients with distinct genetic profiles, complications, and rates of disease progression.

Cluster 1 is generally similar to the classical type 1 diabetes: its onset occurred when young, otherwise healthy, individuals had an autoimmune disease that made them unable to produce insulin. Patients in cluster 2 were similar to those in cluster 1, but their inability to produce insulin was not due to immune disease. Those in cluster 2 also had the highest risk of retinopathy.

Patients in cluster 3 were severely insulin-resistant and had a higher risk of developing diabetic kidney disease than those in clusters 4 and 5. Individuals in cluster 4 had mild obesity-related diabetes, and cluster 5 included those with mild age-related diabetes.

Rob Sladek, a geneticist at McGill University in Canada who was not involved in the study, notes in an accompanying editorial that classifying “more refined subtypes” of diabetes will help identify targeted therapies and improve the accuracy of clinical outcome predictions.

“This is definitely the future of how we think about diabetes as a disease," Salem tells the BBC. “There is still a massively unknown quantity—it may well be that worldwide there are 500 subgroups depending on genetic and local environment effects. Their analysis has five clusters, but that may grow.”

 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Application of TruBIOME™ to Increase Mouse Model Reproducibility
Application of TruBIOME™ to Increase Mouse Model Reproducibility
With this application note from Taconic, learn about the effects of the microbiome on reproducibility and predictability and how TruBIOME™ helps researchers generate custom microbiota mouse models!
Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.